Skip to product information
1 of 6

G-NiiB

G-NiiB M3CRC Non-Invasive Colorectal Cancer Risk Prediction Test 1pc

G-NiiB M3CRC Non-Invasive Colorectal Cancer Risk Prediction Test 1pc

Regular price $389.00 USD
Regular price $0.00 USD Sale price $389.00 USD
Sale Sold out

Origin

Hong Kong

Product Description

G-NiiB M3CRC Non-Invasive Colorectal Cancer Risk Prediction Test, researched and developed by the Faculty of Medicine of A Renowned University in Hong Kong, provides 3 risk prediction including colon cancer, non-advanced adenoma and recurrent adenoma. The sensitivity of colon cancer detection is 94%^, which is comparable to colonoscopy. The risk of adenoma recurrence and less than 5mm non-advanced adenoma can be detected. The sensitivity of adenoma recurrence detection is 90%^. The prediction test only requires stool collection which is non-invasive and painless.

Contained in this box:
Stool collection tools

^ The Chinese University of Hong Kong. CUHK Develops a Novel Faecal Test that can Detect Polyps and Early Colon Cancers with Sensitivity Over 90% [Press Release]. 2021




View full details